Is the apico-basal gradient larger than the transmural gradient?
de Bakker
Jacques M T
JM
OptHof
Tobias
T
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002839:Chromans / Q000494:pharmacology; D004285:Dogs; D006321:Heart / Q000502:physiology*; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology; D010627:Phenethylamines / Q000494:pharmacology; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024661:Potassium Channels, Inwardly Rectifying / Q000037:antagonists & inhibitors; D013449:Sulfonamides / Q000494:pharmacology; D016276:Ventricular Function
D002839:Chromans; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D024661:Potassium Channels, Inwardly Rectifying; D013449:Sulfonamides; C103474:6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane; C063533:dofetilide